60 Degrees Pharmaceuticals Partners With University of Southern Mississippi on Research
The partnership will evaluate castanospermine in nonclinical models of alpha-gal syndrome.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
3 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
60 Degrees Pharmaceuticals Partners With University to Study Castanospermine
60 Degrees Pharmaceuticals announced a partnership with the University of Southern Mississippi to evaluate castanospermine in nonclinical models of alpha-gal syndrome.
60 Degrees Pharmaceuticals Partners With University of Southern Mississippi
The companies will evaluate castanospermine in nonclinical models of alpha-gal syndrome.